CONVERSION FROM CYCLOSPORINE TO FK506 FOR SALVAGE OF IMMUNOCOMPROMISED PEDIATRIC LIVER ALLOGRAFTS EFFICACY, TOXICITY, AND DOSE REGIMEN IN 23 CHILDREN

RAYMOND REDING, PIERRE E. WALLEMACQ, MONIQUE E. LAMY, JACQUES RAHIER, CHRISTINE SEMPOUX, BENOIT DEBANDE, JACQUES JAMART, ANDREW BARKER, ETIENNE SOKAL, JEAN DE VILLE DE GOYET, DIDIER MOULIN, STÉPHANE CLEMENT DE CLETY, JEAN-BERNARD OTTE
  • Transplantation, January 1994, Wolters Kluwer Health
  • DOI: 10.1097/00007890-199401000-00017

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1097/00007890-199401000-00017

The following have contributed to this page: Professor Jean de VILLE de GOYET